Phase I study of FR901228 [romidepsin] in patients with recurrent or refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia

Trial Profile

Phase I study of FR901228 [romidepsin] in patients with recurrent or refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia

Not stated
Phase of Trial: Phase I

Latest Information Update: 23 Aug 2005

At a glance

  • Drugs Romidepsin (Primary)
  • Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top